London Psychedelics?

London's Clerkenwell Health will have a focus on the therapeutic uses of fungally-derived psychedelic drugs (https://www.theguardian.com/science/2022/may/09/europes-first-psychedelic-drug-trial-firm-to-open-in-london). Its first trial will look at psilocybin's (from 'magic mushrooms') potential use, in relieving anxiety associated with terminal illness and end-of-life care. That seems relatively uncontentious. Clerkenwell Health might have more problems, if they intend using psychedelics, to make 'well' people 'happy'?